VanEck Associates’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$307K Buy
+10,012
New +$225K ﹤0.01% 1281

Other funds holding CAI

VanEck Associates's CAI Position: Q3 2026 in Review

VanEck Associates opened a new position in Caris Life Sciences (CAI) in Q3 2026: 10,012 shares worth $307K. The stake represents ﹤0.01% of the portfolio and ranks #1281 among its holdings.

328 funds tracked by Wall St. Rank hold CAI as of Q3 2026.

  • VanEck Associates held 10,012 shares of Caris Life Sciences worth $307K as of Q3 2026.
  • Caris Life Sciences was a new VanEck Associates position in Q3 2026.
  • Caris Life Sciences made up ﹤0.01% of VanEck Associates's portfolio in Q3 2026, its #1281 holding.
  • 328 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.

Based on VanEck Associates's 13F filing for Q3 2026, filed 13 Nov 2026.